{"id": "article-24904_0", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Continuing Education Activity", "content": "Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a group of inherited kidney disorders. It is usually characterized by progressive renal insufficiency, tubulointerstitial nephropathy, and bland urinary sediment. This condition is inherited in an autosomal dominant manner. It must be promptly diagnosed and treated to avoid the high morbidity and mortality associated with this condition. This activity describes the etiology, evaluation, and treatment of autosomal dominant tubulointerstitial kidney disease and highlights the role of the interprofessional team in evaluating and improving care for patients with this condition.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Continuing Education Activity. Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a group of inherited kidney disorders. It is usually characterized by progressive renal insufficiency, tubulointerstitial nephropathy, and bland urinary sediment. This condition is inherited in an autosomal dominant manner. It must be promptly diagnosed and treated to avoid the high morbidity and mortality associated with this condition. This activity describes the etiology, evaluation, and treatment of autosomal dominant tubulointerstitial kidney disease and highlights the role of the interprofessional team in evaluating and improving care for patients with this condition."}
{"id": "article-24904_1", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Continuing Education Activity", "content": "Objectives: Identify the etiology of autosomal dominant tubulointerstitial kidney disease. Describe the appropriate evaluation of autosomal dominant tubulointerstitial kidney disease. Outline the management options available for autosomal dominant tubulointerstitial kidney disease. Review interprofessional team strategies for improving care coordination and communication to advance autosomal dominant tubulointerstitial kidney disease and improve outcomes. Access free multiple choice questions on this topic.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Continuing Education Activity. Objectives: Identify the etiology of autosomal dominant tubulointerstitial kidney disease. Describe the appropriate evaluation of autosomal dominant tubulointerstitial kidney disease. Outline the management options available for autosomal dominant tubulointerstitial kidney disease. Review interprofessional team strategies for improving care coordination and communication to advance autosomal dominant tubulointerstitial kidney disease and improve outcomes. Access free multiple choice questions on this topic."}
{"id": "article-24904_2", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Introduction", "content": "Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a group of inherited kidney disorders. It is usually characterized by\u00a0progressive renal insufficiency, tubulointerstitial nephropathy, and bland urinary sediment. Multiple names have been\u00a0suggested for this group of disorders, including \u2018familial juvenile hyperuricemic nephropathy (FJHN),\u2019 \u2018medullary cystic kidney disease (MCKD) type 2\u2019, \u2018uromodulin-associated kidney disease (UAKD),\u2019 UMOD-related diseases, and \u2018MCKD type 1\u2019. However, the variety of these names, and the idea that cysts are not pathognomonic, generates confusion. Kidney Disease: Improving Global Outcomes (KDIGO)\u00a0suggests the adoption of new terminology for these diseases using\u00a0a single name\u00a0\u2018autosomal dominant tubulointerstitial kidney disease\u2019 (ADTKD)\u00a0adjoining a gene-based subclassification and diagnostic criteria. These recommendations are anticipated to bring about homogeneity in the characterization of this monogenic group of diseases.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Introduction. Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a group of inherited kidney disorders. It is usually characterized by\u00a0progressive renal insufficiency, tubulointerstitial nephropathy, and bland urinary sediment. Multiple names have been\u00a0suggested for this group of disorders, including \u2018familial juvenile hyperuricemic nephropathy (FJHN),\u2019 \u2018medullary cystic kidney disease (MCKD) type 2\u2019, \u2018uromodulin-associated kidney disease (UAKD),\u2019 UMOD-related diseases, and \u2018MCKD type 1\u2019. However, the variety of these names, and the idea that cysts are not pathognomonic, generates confusion. Kidney Disease: Improving Global Outcomes (KDIGO)\u00a0suggests the adoption of new terminology for these diseases using\u00a0a single name\u00a0\u2018autosomal dominant tubulointerstitial kidney disease\u2019 (ADTKD)\u00a0adjoining a gene-based subclassification and diagnostic criteria. These recommendations are anticipated to bring about homogeneity in the characterization of this monogenic group of diseases."}
{"id": "article-24904_3", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Introduction", "content": "This condition is inherited in an autosomal dominant manner. To date, many different gene mutations that cause ADTKD have been detected, such as uromodulin (UMOD), renin (REN),\u00a0mucin-1 (MUC1), hepatocyte nuclear factor 1\u03b2 (HNF1B), and SEC. 61A1\u00a0mutations. [1] [2] These genes encode different proteins, which are imperative for normal renal function. The clinical scenario is varied and non-specific, and it is dependent on the type of gene mutation. The clinical manifestation of diseases associated with mutations in MUC1, UMOD, and REN appears to be limited to the kidney; however, HNF1B mutations\u00a0cause variable extrarenal manifestations. [3] It is difficult to diagnose this condition because it is a rare and\u00a0recently identified disorder that is not well known to most primary health care providers and nephrologists. [4]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Introduction. This condition is inherited in an autosomal dominant manner. To date, many different gene mutations that cause ADTKD have been detected, such as uromodulin (UMOD), renin (REN),\u00a0mucin-1 (MUC1), hepatocyte nuclear factor 1\u03b2 (HNF1B), and SEC. 61A1\u00a0mutations. [1] [2] These genes encode different proteins, which are imperative for normal renal function. The clinical scenario is varied and non-specific, and it is dependent on the type of gene mutation. The clinical manifestation of diseases associated with mutations in MUC1, UMOD, and REN appears to be limited to the kidney; however, HNF1B mutations\u00a0cause variable extrarenal manifestations. [3] It is difficult to diagnose this condition because it is a rare and\u00a0recently identified disorder that is not well known to most primary health care providers and nephrologists. [4]"}
{"id": "article-24904_4", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Etiology", "content": "Autosomal dominant tubulointerstitial kidney disease is a rare renal disorder caused by variable mutations in different genes. As discussed previously, at least five different gene mutations have been observed to result in this group of disorders.\u00a0An autosomal dominant inheritance pattern inherits this disorder.\u00a0MUC1\u00a0gene encodes a mucin-1 protein,\u00a0UMOD\u00a0gene encodes uromodulin protein (previously known as Tamm-Horsfall protein),\u00a0HNF1B\u00a0gene encodes hepatocyte nuclear factor 1 beta,\u00a0REN\u00a0gene encodes renin, and\u00a0SEC61A1\u00a0gene encodes translocon subunit SEC61A. [5] The details of the pathogenesis underlying these genetic mutations will be discussed in the pathophysiology section of this article.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Etiology. Autosomal dominant tubulointerstitial kidney disease is a rare renal disorder caused by variable mutations in different genes. As discussed previously, at least five different gene mutations have been observed to result in this group of disorders.\u00a0An autosomal dominant inheritance pattern inherits this disorder.\u00a0MUC1\u00a0gene encodes a mucin-1 protein,\u00a0UMOD\u00a0gene encodes uromodulin protein (previously known as Tamm-Horsfall protein),\u00a0HNF1B\u00a0gene encodes hepatocyte nuclear factor 1 beta,\u00a0REN\u00a0gene encodes renin, and\u00a0SEC61A1\u00a0gene encodes translocon subunit SEC61A. [5] The details of the pathogenesis underlying these genetic mutations will be discussed in the pathophysiology section of this article."}
{"id": "article-24904_5", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Epidemiology", "content": "Since autosomal dominant tubulointerstitial kidney disease is a rare and recently identified disorder, the exact prevalence has not been determined, neither in the United States of America nor worldwide. [5] There is no difference in the incidence rate between males and females because this condition is inherited in an autosomal dominant manner. The child, either sex, has a\u00a050% chance of inheriting the mutated gene.\u00a0The mean age of end-stage\u00a0renal disease (ESRD) is 45 years old, but the range is variable, starting from 17 years old up to 75 years old. [6] No geographic or sex differences are reported.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Epidemiology. Since autosomal dominant tubulointerstitial kidney disease is a rare and recently identified disorder, the exact prevalence has not been determined, neither in the United States of America nor worldwide. [5] There is no difference in the incidence rate between males and females because this condition is inherited in an autosomal dominant manner. The child, either sex, has a\u00a050% chance of inheriting the mutated gene.\u00a0The mean age of end-stage\u00a0renal disease (ESRD) is 45 years old, but the range is variable, starting from 17 years old up to 75 years old. [6] No geographic or sex differences are reported."}
{"id": "article-24904_6", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Epidemiology", "content": "ADTKD-UMOD may present\u00a0in adolescence with gout; hyperuricemia\u00a0is highly prevalent. Chronic kidney disease (CKD) is often diagnosed in late adolescence or early adulthood. ADTKD-REN\u00a0could present with\u00a0hyperkalemia, anemia, and CKD as early as infancy. ADTKD-MUC1\u00a0patients generally develop CKD in their early twenties. ADTKD-HNF1B\u00a0could present with genitourinary abnormalities in childhood, gout or diabetes in the teenage years, and CKD in the third decade of life. Extrarenal abnormalities are also possible. All subtypes usually lead to progressive ESRD, occurring typically\u00a0between 25 and 70 years of age, and those with gout experience its onset between the age range of 3 and 51 years. [7] [8] For instance, a study in Ireland reported that\u00a0ADTKD was the underlying cause of ESRD in at least 0.54% of patients. [5]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Epidemiology. ADTKD-UMOD may present\u00a0in adolescence with gout; hyperuricemia\u00a0is highly prevalent. Chronic kidney disease (CKD) is often diagnosed in late adolescence or early adulthood. ADTKD-REN\u00a0could present with\u00a0hyperkalemia, anemia, and CKD as early as infancy. ADTKD-MUC1\u00a0patients generally develop CKD in their early twenties. ADTKD-HNF1B\u00a0could present with genitourinary abnormalities in childhood, gout or diabetes in the teenage years, and CKD in the third decade of life. Extrarenal abnormalities are also possible. All subtypes usually lead to progressive ESRD, occurring typically\u00a0between 25 and 70 years of age, and those with gout experience its onset between the age range of 3 and 51 years. [7] [8] For instance, a study in Ireland reported that\u00a0ADTKD was the underlying cause of ESRD in at least 0.54% of patients. [5]"}
{"id": "article-24904_7", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Epidemiology", "content": "ADTKD is believed to be one of the commonest monogenic forms of renal disease, and overall it accounts for around 5% of all monogenic causes of CKD. [9] The prevalence of the\u00a0various types of ADTKD has not been widely studied; however, ADTKD-UMOD and ADTKD-MUC1 are\u00a0perhaps more frequently encountered than ADTKD\u00a0due to mutations in HNF1B or REN. In many studies, ADTKD-UMOD was the most common genetic kidney disease after ADPKD, with a population prevalence of 9 per million. [10]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Epidemiology. ADTKD is believed to be one of the commonest monogenic forms of renal disease, and overall it accounts for around 5% of all monogenic causes of CKD. [9] The prevalence of the\u00a0various types of ADTKD has not been widely studied; however, ADTKD-UMOD and ADTKD-MUC1 are\u00a0perhaps more frequently encountered than ADTKD\u00a0due to mutations in HNF1B or REN. In many studies, ADTKD-UMOD was the most common genetic kidney disease after ADPKD, with a population prevalence of 9 per million. [10]"}
{"id": "article-24904_8", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology", "content": "In autosomal dominant tubulointerstitial kidney disease-MUC1, the\u00a0MUC1\u00a0gene is located on chromosome 1q21. It is thought that most\u00a0MUC1\u00a0mutations are caused by cytosine duplication within a seven-cytosine stretch in the variable-number tandem repeats (VNTR) region that usually produces a frameshift mutation. This mutated gene produces an abnormal protein known as the MUC1 frameshift protein (MUC1fs). Accumulating this abnormal protein (MUC1fs) in the renal tubular epithelial cells may be considered an important pathogenic factor in the pathophysiology of ADTKD-MUC1; in addition, positive staining of (MUC1fs) in the\u00a0urinary exfoliated cells and renal tubular epithelial cells could help to diagnose this condition. [1]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology. In autosomal dominant tubulointerstitial kidney disease-MUC1, the\u00a0MUC1\u00a0gene is located on chromosome 1q21. It is thought that most\u00a0MUC1\u00a0mutations are caused by cytosine duplication within a seven-cytosine stretch in the variable-number tandem repeats (VNTR) region that usually produces a frameshift mutation. This mutated gene produces an abnormal protein known as the MUC1 frameshift protein (MUC1fs). Accumulating this abnormal protein (MUC1fs) in the renal tubular epithelial cells may be considered an important pathogenic factor in the pathophysiology of ADTKD-MUC1; in addition, positive staining of (MUC1fs) in the\u00a0urinary exfoliated cells and renal tubular epithelial cells could help to diagnose this condition. [1]"}
{"id": "article-24904_9", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology", "content": "In ADTKD-UMOD, endoplasmic reticulum stress may occur due to the retention of the mutant uromodulin (mUMOD) protein inside the endoplasmic reticulum (ER) of tubular epithelial cells in the thick ascending limb of the renal tubules. This will lead to tubular cell death,\u00a0decreased cellular release, urinary excretion of the wild-type protein, and chronic kidney disease. [11] [12] Additionally, the defective biogenesis and intracellular uromodulin transport affect the Na-K-2Cl cotransporter\u00a0resulting in defective urinary concentration and mild volume depletion, secondarily increasing proximal reabsorption of uric acid, leading to\u00a0hyperuricemia. [13] [14] About two-thirds of the mutations that cause ADTKD-UMOD\u00a0(mUMOD) involve cysteine residues, and no mutations are reported resulting in\u00a0loss of transcription or truncation. All these findings imply the important role of the\u00a0mutant uromodulin (mUMOD) protein in the pathophysiology of ADTKD-UMOD. [15]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology. In ADTKD-UMOD, endoplasmic reticulum stress may occur due to the retention of the mutant uromodulin (mUMOD) protein inside the endoplasmic reticulum (ER) of tubular epithelial cells in the thick ascending limb of the renal tubules. This will lead to tubular cell death,\u00a0decreased cellular release, urinary excretion of the wild-type protein, and chronic kidney disease. [11] [12] Additionally, the defective biogenesis and intracellular uromodulin transport affect the Na-K-2Cl cotransporter\u00a0resulting in defective urinary concentration and mild volume depletion, secondarily increasing proximal reabsorption of uric acid, leading to\u00a0hyperuricemia. [13] [14] About two-thirds of the mutations that cause ADTKD-UMOD\u00a0(mUMOD) involve cysteine residues, and no mutations are reported resulting in\u00a0loss of transcription or truncation. All these findings imply the important role of the\u00a0mutant uromodulin (mUMOD) protein in the pathophysiology of ADTKD-UMOD. [15]"}
{"id": "article-24904_10", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology", "content": "In autosomal dominant tubulointerstitial kidney disease-SEC61A1,\u00a0this condition is associated with\u00a0missense mutations in\u00a0SEC61A1. It is responsible for encoding the alpha subunit of\u00a0endoplasmatic reticular membrane translocon SEC61. Many studies confirmed that the normal function of the SEC61 complex and its translocon is essential for normal kidney development. [16]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology. In autosomal dominant tubulointerstitial kidney disease-SEC61A1,\u00a0this condition is associated with\u00a0missense mutations in\u00a0SEC61A1. It is responsible for encoding the alpha subunit of\u00a0endoplasmatic reticular membrane translocon SEC61. Many studies confirmed that the normal function of the SEC61 complex and its translocon is essential for normal kidney development. [16]"}
{"id": "article-24904_11", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology", "content": "In autosomal dominant tubulointerstitial kidney disease-REN,\u00a0the disease is mainly caused by non-truncating mutations in the first exon of the REN gene that affect the protein leader peptide residues. The type of the mutation is either\u00a0missense changes like (L16R, W10R, W17R, and C20R) or\u00a0an in-frame deletion (L16del). Another study identified a new novel renin mutation in exon 10 of the REN gene. These mutations can lead to endoplasmic reticulum stress and unfolded protein response activation, leading to improper renal development. [17]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology. In autosomal dominant tubulointerstitial kidney disease-REN,\u00a0the disease is mainly caused by non-truncating mutations in the first exon of the REN gene that affect the protein leader peptide residues. The type of the mutation is either\u00a0missense changes like (L16R, W10R, W17R, and C20R) or\u00a0an in-frame deletion (L16del). Another study identified a new novel renin mutation in exon 10 of the REN gene. These mutations can lead to endoplasmic reticulum stress and unfolded protein response activation, leading to improper renal development. [17]"}
{"id": "article-24904_12", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology", "content": "In autosomal dominant tubulointerstitial kidney disease-HNF1B,\u00a0the\u00a0HNF1B\u00a0gene has an essential role in early embryonic development. It is also known as transcription factor-2 (TCF2). This gene is located on chromosome 17q12, which codes for protein hepatocyte nuclear factor 1 homeobox B. Since\u00a0HNF1B\u00a0is expressed in the body's variable tissues like the kidney, liver, pancreas, and genitourinary tract, this may explain the variable clinical presentations of the\u00a0HNF1B-related disorders. It was\u00a0found that loss of\u00a0HNF1b\u00a0could induce epithelial-mesenchymal transition. This transition will ultimately lead to kidney fibrosis by\u00a0up-regulation of the expression of transforming growth factor\u2212\u03b2 ligands in renal\u00a0epithelial cells. [18]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Pathophysiology. In autosomal dominant tubulointerstitial kidney disease-HNF1B,\u00a0the\u00a0HNF1B\u00a0gene has an essential role in early embryonic development. It is also known as transcription factor-2 (TCF2). This gene is located on chromosome 17q12, which codes for protein hepatocyte nuclear factor 1 homeobox B. Since\u00a0HNF1B\u00a0is expressed in the body's variable tissues like the kidney, liver, pancreas, and genitourinary tract, this may explain the variable clinical presentations of the\u00a0HNF1B-related disorders. It was\u00a0found that loss of\u00a0HNF1b\u00a0could induce epithelial-mesenchymal transition. This transition will ultimately lead to kidney fibrosis by\u00a0up-regulation of the expression of transforming growth factor\u2212\u03b2 ligands in renal\u00a0epithelial cells. [18]"}
{"id": "article-24904_13", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Histopathology", "content": "Histology of autosomal dominant tubulointerstitial kidney disease shows interstitial fibrosis with normal glomeruli and tubular atrophy. Lamellation and thickening of tubular basement membranes are frequent findings. [3] [19] [7] [20] Tubular dilatation could be seen, and tubular microcysts have been observed. Immunofluorescence for immunoglobulins and complement is negative. Electron microscopy provides little or no additional information; however,\u00a0it may reveal the accumulation of mUMOD in the ER\u00a0of thick ascending loop cells. [21] The following is the list of changes that have been reported in association with various types of ADTKD: Interstitial fibrosis Tubular atrophy Thickening and lamellation of tubular basement membranes Possibly tubular dilatation (microcysts) Negative immunofluorescence for complement and immunoglobulins", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Histopathology. Histology of autosomal dominant tubulointerstitial kidney disease shows interstitial fibrosis with normal glomeruli and tubular atrophy. Lamellation and thickening of tubular basement membranes are frequent findings. [3] [19] [7] [20] Tubular dilatation could be seen, and tubular microcysts have been observed. Immunofluorescence for immunoglobulins and complement is negative. Electron microscopy provides little or no additional information; however,\u00a0it may reveal the accumulation of mUMOD in the ER\u00a0of thick ascending loop cells. [21] The following is the list of changes that have been reported in association with various types of ADTKD: Interstitial fibrosis Tubular atrophy Thickening and lamellation of tubular basement membranes Possibly tubular dilatation (microcysts) Negative immunofluorescence for complement and immunoglobulins"}
{"id": "article-24904_14", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical", "content": "Autosomal dominant tubulointerstitial kidney disease is a group of inherited kidney disorders caused by different gene mutations that share the same histological findings. Occasionally, nephronophthisis may\u00a0appear in young\u00a0individuals with features suggestive of ADTKD; however, autosomal recessive inheritance differentiates it from ADTKD3. [22] The rate of decline of the estimated glomerular filtration rate is\u00a0exceedingly variable in ADTKD-MUC1, ADTKD-UMOD, and ADTKD-HNF1B. [19] [7] The urinary sediment is\u00a0generally normal, but microhematuria can occasionally be seen. Proteinuria is either mild or completely absent. Glomerular involvement has been rarely found, such as\u00a0in glomerulocystic disease and secondary focal segmental glomerulosclerosis. [23] The initially normal kidney size\u00a0starts to decline with advancing disease. Patients\u00a0generally have no history of hypertension preceding impaired\u00a0renal function. With progression, blood pressure could increase, but typically only modestly.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical. Autosomal dominant tubulointerstitial kidney disease is a group of inherited kidney disorders caused by different gene mutations that share the same histological findings. Occasionally, nephronophthisis may\u00a0appear in young\u00a0individuals with features suggestive of ADTKD; however, autosomal recessive inheritance differentiates it from ADTKD3. [22] The rate of decline of the estimated glomerular filtration rate is\u00a0exceedingly variable in ADTKD-MUC1, ADTKD-UMOD, and ADTKD-HNF1B. [19] [7] The urinary sediment is\u00a0generally normal, but microhematuria can occasionally be seen. Proteinuria is either mild or completely absent. Glomerular involvement has been rarely found, such as\u00a0in glomerulocystic disease and secondary focal segmental glomerulosclerosis. [23] The initially normal kidney size\u00a0starts to decline with advancing disease. Patients\u00a0generally have no history of hypertension preceding impaired\u00a0renal function. With progression, blood pressure could increase, but typically only modestly."}
{"id": "article-24904_15", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical", "content": "The clinical manifestations are widely variable and gene-dependent. The following is a discussion that encompasses the most likely observed clinical features with each gene mutation:", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical. The clinical manifestations are widely variable and gene-dependent. The following is a discussion that encompasses the most likely observed clinical features with each gene mutation:"}
{"id": "article-24904_16", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical", "content": "ADTKD-MUC1 was previously called medullary cystic kidney disease type 1. This disease is characterized by progressive tubulointerstitial fibrosis that ultimately leads to ESRD. ESRD typically starts in adulthood, but it may occur at any age, from 20 years old to 70 years old. There are no other systemic manifestations. Since this disease is transmitted in an autosomal dominant manner, a family history of chronic renal insufficiency is an important key point to figuring out this disease. [24]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical. ADTKD-MUC1 was previously called medullary cystic kidney disease type 1. This disease is characterized by progressive tubulointerstitial fibrosis that ultimately leads to ESRD. ESRD typically starts in adulthood, but it may occur at any age, from 20 years old to 70 years old. There are no other systemic manifestations. Since this disease is transmitted in an autosomal dominant manner, a family history of chronic renal insufficiency is an important key point to figuring out this disease. [24]"}
{"id": "article-24904_17", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical", "content": "ADTKD-UMOD\u00a0was\u00a0known historically as familial juvenile hyperuricemic nephropathy type 1 (FJHN1),\u00a0uromodulin-associated kidney disease (UMOD-associated kidney disease), and medullary cystic kidney disease type 2 (MCKD2). The clinical manifestation is slowly progressive chronic kidney disease, usually noticed in the teen years, and progression to\u00a0ESRD between the fourth and seventh decades of life. Other important clinical features are gout and hyperuricemia, resulting from inappropriately decreased fractional urate excretion that usually occurs as early as the teenage years. [25]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical. ADTKD-UMOD\u00a0was\u00a0known historically as familial juvenile hyperuricemic nephropathy type 1 (FJHN1),\u00a0uromodulin-associated kidney disease (UMOD-associated kidney disease), and medullary cystic kidney disease type 2 (MCKD2). The clinical manifestation is slowly progressive chronic kidney disease, usually noticed in the teen years, and progression to\u00a0ESRD between the fourth and seventh decades of life. Other important clinical features are gout and hyperuricemia, resulting from inappropriately decreased fractional urate excretion that usually occurs as early as the teenage years. [25]"}
{"id": "article-24904_18", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical", "content": "ADTKD-REN was\u00a0known\u00a0previously as familial juvenile hyperuricemic nephropathy type 2 (FJHN2).\u00a0This disease\u00a0is\u00a0characterized by hypo-proliferative anemia with a low hemoglobin concentration in the first decade of life. The clinical symptoms of CKD and hyperuricemia start in childhood or adolescence. This condition is also characterized by bland urinary sediment,\u00a0mildly elevated serum potassium concentration,\u00a0slightly decreased blood pressure,\u00a0polyuria, and low plasma renin activity.\u00a0Patients usually progress to ESRD in their fourth to sixth decade of life. [17]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical. ADTKD-REN was\u00a0known\u00a0previously as familial juvenile hyperuricemic nephropathy type 2 (FJHN2).\u00a0This disease\u00a0is\u00a0characterized by hypo-proliferative anemia with a low hemoglobin concentration in the first decade of life. The clinical symptoms of CKD and hyperuricemia start in childhood or adolescence. This condition is also characterized by bland urinary sediment,\u00a0mildly elevated serum potassium concentration,\u00a0slightly decreased blood pressure,\u00a0polyuria, and low plasma renin activity.\u00a0Patients usually progress to ESRD in their fourth to sixth decade of life. [17]"}
{"id": "article-24904_19", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical", "content": "ADTKD-SEC61A1\u00a0is a newly discovered disease caused by a mutation in\u00a0SEC61A1. Since it is a new disease, the whole clinical picture is not conspicuous. To date, very few families have been identified with this disorder. In one family, dysplastic kidneys, anemia, and intrauterine growth retardation were present. In another family, anemia,\u00a0neutropenia with abscess formation, and chronic kidney disease were documented. [6]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical. ADTKD-SEC61A1\u00a0is a newly discovered disease caused by a mutation in\u00a0SEC61A1. Since it is a new disease, the whole clinical picture is not conspicuous. To date, very few families have been identified with this disorder. In one family, dysplastic kidneys, anemia, and intrauterine growth retardation were present. In another family, anemia,\u00a0neutropenia with abscess formation, and chronic kidney disease were documented. [6]"}
{"id": "article-24904_20", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical", "content": "A mutation in the TCF2 gene causes ADTKD-HNF1B. The kidney and the pancreas express the homeodomain-containing transcription factors hepatocyte nuclear factor 1 alpha and 1 beta.\u00a0Research has identified that mutations in this gene may cause the maturity-onset diabetes of youth (MODY), but further studies explicate that mutations in this gene may also lead to renal manifestations. The\u00a0varied clinical manifestations and the fact that these clinical manifestations are not\u00a0present consistently in all affected family members made diagnosing this condition difficult. The non-renal manifestations may include maturity-onset diabetes mellitus of the young, abnormal liver function tests of unclear etiology, genito-urinary tract malformations, and hyperuricemia with gout. In adolescence, hypomagnesemia may occur in some individuals. The renal manifestations are common in adulthood and often involve\u00a0numerous renal cysts, congenital solitary kidney, congenital anomalies of the kidney and urinary tract system, renal dysplasia, and hypoplastic kidneys. [26] [6]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- History and Physical. A mutation in the TCF2 gene causes ADTKD-HNF1B. The kidney and the pancreas express the homeodomain-containing transcription factors hepatocyte nuclear factor 1 alpha and 1 beta.\u00a0Research has identified that mutations in this gene may cause the maturity-onset diabetes of youth (MODY), but further studies explicate that mutations in this gene may also lead to renal manifestations. The\u00a0varied clinical manifestations and the fact that these clinical manifestations are not\u00a0present consistently in all affected family members made diagnosing this condition difficult. The non-renal manifestations may include maturity-onset diabetes mellitus of the young, abnormal liver function tests of unclear etiology, genito-urinary tract malformations, and hyperuricemia with gout. In adolescence, hypomagnesemia may occur in some individuals. The renal manifestations are common in adulthood and often involve\u00a0numerous renal cysts, congenital solitary kidney, congenital anomalies of the kidney and urinary tract system, renal dysplasia, and hypoplastic kidneys. [26] [6]"}
{"id": "article-24904_21", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation", "content": "Since autosomal dominant tubulointerstitial kidney disease is a rare condition and difficult to predict, it is prudent for health care providers to\u00a0consider\u00a0this disease, especially\u00a0if the patient has signs and symptoms of renal failure at a young age with a family history of end-stage renal disease. However, even with limited knowledge, nephrologists can obtain the diagnosis and improve patient care with the help of the following criteria:", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation. Since autosomal dominant tubulointerstitial kidney disease is a rare condition and difficult to predict, it is prudent for health care providers to\u00a0consider\u00a0this disease, especially\u00a0if the patient has signs and symptoms of renal failure at a young age with a family history of end-stage renal disease. However, even with limited knowledge, nephrologists can obtain the diagnosis and improve patient care with the help of the following criteria:"}
{"id": "article-24904_22", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation -- Criteria for Suspecting a Diagnosis of ADTKD", "content": "Family history is compatible with the autosomal dominant pattern of inheritance of CKD\u00a0in line with\u00a0clinical characteristics (as mentioned above). In the absence of a family history of CKD in line with clinical characteristics, demonstration of relevant\u00a0histology on\u00a0renal biopsy or extrarenal features\u00a0compatible with HNF1B mutation, or history of early-onset hyperuricemia\u00a0with or without gout.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation -- Criteria for Suspecting a Diagnosis of ADTKD. Family history is compatible with the autosomal dominant pattern of inheritance of CKD\u00a0in line with\u00a0clinical characteristics (as mentioned above). In the absence of a family history of CKD in line with clinical characteristics, demonstration of relevant\u00a0histology on\u00a0renal biopsy or extrarenal features\u00a0compatible with HNF1B mutation, or history of early-onset hyperuricemia\u00a0with or without gout."}
{"id": "article-24904_23", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation -- Criteria for Establishing the Diagnosis of ADTKD", "content": "Family history is compatible with the autosomal dominant pattern of inheritance of CKD\u00a0in line with\u00a0clinical characteristics (as mentioned above) and\u00a0relevant histology in at least one affected relative. (Of note, it is not possible to establish a definitive diagnosis by kidney biopsy alone)or Demonstration of mutation in at least one of the four genes in\u00a0the patient or at least one family member The variable rate of decline in renal function with the mean age of end-stage renal disease is approximately 45 years, but the range is 17 years up to 75 years. [6]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation -- Criteria for Establishing the Diagnosis of ADTKD. Family history is compatible with the autosomal dominant pattern of inheritance of CKD\u00a0in line with\u00a0clinical characteristics (as mentioned above) and\u00a0relevant histology in at least one affected relative. (Of note, it is not possible to establish a definitive diagnosis by kidney biopsy alone)or Demonstration of mutation in at least one of the four genes in\u00a0the patient or at least one family member The variable rate of decline in renal function with the mean age of end-stage renal disease is approximately 45 years, but the range is 17 years up to 75 years. [6]"}
{"id": "article-24904_24", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation", "content": "In\u00a0ADTKD- MUC1, genetic diagnosis is not straightforward.\u00a0It is essential to know that testing for the MUC1 gene\u00a0mutation is not a direct mutational analysis, and this test is not performed at commercial clinical laboratories at this time. A recent study was conducted to detect\u00a0MUC1fs protein by\u00a0immunostaining the MUC1fs protein on the epithelial tissues and the urinary cell smears in individuals with ADTKD- MUC1, and the result is promising. Still, it is not readily available at the clinical lab yet. [27]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation. In\u00a0ADTKD- MUC1, genetic diagnosis is not straightforward.\u00a0It is essential to know that testing for the MUC1 gene\u00a0mutation is not a direct mutational analysis, and this test is not performed at commercial clinical laboratories at this time. A recent study was conducted to detect\u00a0MUC1fs protein by\u00a0immunostaining the MUC1fs protein on the epithelial tissues and the urinary cell smears in individuals with ADTKD- MUC1, and the result is promising. Still, it is not readily available at the clinical lab yet. [27]"}
{"id": "article-24904_25", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation", "content": "In\u00a0ADTKD- UMOD, the diagnosis may be made based on the appropriate and relevant clinical scenario and the knowledge that another family member has been identified with a UMOD mutation on genetic testing. However,\u00a0uromodulin genetic analysis is readily available at commercial clinical laboratories. [25]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation. In\u00a0ADTKD- UMOD, the diagnosis may be made based on the appropriate and relevant clinical scenario and the knowledge that another family member has been identified with a UMOD mutation on genetic testing. However,\u00a0uromodulin genetic analysis is readily available at commercial clinical laboratories. [25]"}
{"id": "article-24904_26", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation", "content": "In\u00a0ADTKD- REN, genetic analysis of the REN gene should always be used to make the diagnosis. When the renin and aldosterone are stimulated, the levels are in the low normal range in most patients, making this type of measurement inadequate for making the diagnosis. [6]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation. In\u00a0ADTKD- REN, genetic analysis of the REN gene should always be used to make the diagnosis. When the renin and aldosterone are stimulated, the levels are in the low normal range in most patients, making this type of measurement inadequate for making the diagnosis. [6]"}
{"id": "article-24904_27", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation", "content": "In\u00a0ADTKD- HNF1B, this condition's\u00a0clinical scenario is widely variable, with different renal and extrarenal clinical manifestations. The\u00a0cost-effective NGS-based strategies allow rapid and simultaneous sequencing of several genes, including HNF1B. [18] In ADTKD- SEC61A1, very few families have been diagnosed with this condition. Currently, the diagnostic criteria are still under development.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Evaluation. In\u00a0ADTKD- HNF1B, this condition's\u00a0clinical scenario is widely variable, with different renal and extrarenal clinical manifestations. The\u00a0cost-effective NGS-based strategies allow rapid and simultaneous sequencing of several genes, including HNF1B. [18] In ADTKD- SEC61A1, very few families have been diagnosed with this condition. Currently, the diagnostic criteria are still under development."}
{"id": "article-24904_28", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management", "content": "Treatment of\u00a0autosomal dominant tubulointerstitial kidney disease mainly focuses on managing the symptoms associated with each type of disease and slowing down the progression to end-stage renal disease.\u00a0It seems reasonable that potentially affected family members be well managed for other risk factors known to worsen or cause CKD, such as arterial hypertension, diabetes, smoking, and obesity, and annual kidney function testing\u00a0is necessary. There are few treatment options for\u00a0children\u00a0at risk for UMOD- or MUC1-associated\u00a0diseases. On the contrary,\u00a0minors with HNF1B- and REN-associated diseases are likely to\u00a0improve from early treatment. Affected individuals should typically be treated according to established CKD guidance. [28] The followings are the most important management options for each sub-type of the disease:", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management. Treatment of\u00a0autosomal dominant tubulointerstitial kidney disease mainly focuses on managing the symptoms associated with each type of disease and slowing down the progression to end-stage renal disease.\u00a0It seems reasonable that potentially affected family members be well managed for other risk factors known to worsen or cause CKD, such as arterial hypertension, diabetes, smoking, and obesity, and annual kidney function testing\u00a0is necessary. There are few treatment options for\u00a0children\u00a0at risk for UMOD- or MUC1-associated\u00a0diseases. On the contrary,\u00a0minors with HNF1B- and REN-associated diseases are likely to\u00a0improve from early treatment. Affected individuals should typically be treated according to established CKD guidance. [28] The followings are the most important management options for each sub-type of the disease:"}
{"id": "article-24904_29", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management", "content": "Regarding ADTKD-UMOD,\u00a0allopurinol or febuxostat are the best treatment options for gout and hyperuricemia. Patients should be encouraged to take one of these medications as soon as gout develops to prevent further gout attacks and gouty tophi. Although starting allopurinol early in life may prevent gout from developing later, the risks and benefits should be discussed thoroughly with the patient or the family if the patient is minor because allopurinol has some important side effects and severe allergic reactions. [29] It is also essential to inform all women of child-bearing age that this medication may have some teratogenic effects and should be stopped before the pregnancy. [30] As kidney disease progression is typically slow, and the\u00a0UMOD\u00a0mutations affect only the kidneys, these patients are excellent renal transplantation candidates.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management. Regarding ADTKD-UMOD,\u00a0allopurinol or febuxostat are the best treatment options for gout and hyperuricemia. Patients should be encouraged to take one of these medications as soon as gout develops to prevent further gout attacks and gouty tophi. Although starting allopurinol early in life may prevent gout from developing later, the risks and benefits should be discussed thoroughly with the patient or the family if the patient is minor because allopurinol has some important side effects and severe allergic reactions. [29] It is also essential to inform all women of child-bearing age that this medication may have some teratogenic effects and should be stopped before the pregnancy. [30] As kidney disease progression is typically slow, and the\u00a0UMOD\u00a0mutations affect only the kidneys, these patients are excellent renal transplantation candidates."}
{"id": "article-24904_30", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management", "content": "Regarding ADTKD-MUC1, there is no specific therapy at present. Optimal therapy to manage chronic kidney disease, such as controlling blood pressure and secondary chronic\u00a0kidney disease changes, are the only available treatments for this condition.\u00a0As progression to end-stage\u00a0renal disease is at a slow rate, and the fact that this condition affects only the kidney,\u00a0these patients are excellent candidates for renal transplantation. [6]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management. Regarding ADTKD-MUC1, there is no specific therapy at present. Optimal therapy to manage chronic kidney disease, such as controlling blood pressure and secondary chronic\u00a0kidney disease changes, are the only available treatments for this condition.\u00a0As progression to end-stage\u00a0renal disease is at a slow rate, and the fact that this condition affects only the kidney,\u00a0these patients are excellent candidates for renal transplantation. [6]"}
{"id": "article-24904_31", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management", "content": "For ADTKD-REN,\u00a0there are several treatment options currently available. As these patients are in\u00a0mild hypovolemia with a low renin state,\u00a0it is essential to avoid the low sodium diet, commonly recommended for chronic kidney disease.\u00a0These patients are prone to develop acute kidney injury on a low sodium diet due to worsening hypotension. Hyperkalemia and mild hypotension could be treated by fludrocortisone or a higher sodium content diet.\u00a0Fludrocortisone may correct hyperkalemia and hypotension and improve hyperuricemia but does not ameliorate hemoglobin levels.\u00a0Fludrocortisone may slow chronic kidney disease progression by lowering renin production (both the normal and the mutated renin). [6]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management. For ADTKD-REN,\u00a0there are several treatment options currently available. As these patients are in\u00a0mild hypovolemia with a low renin state,\u00a0it is essential to avoid the low sodium diet, commonly recommended for chronic kidney disease.\u00a0These patients are prone to develop acute kidney injury on a low sodium diet due to worsening hypotension. Hyperkalemia and mild hypotension could be treated by fludrocortisone or a higher sodium content diet.\u00a0Fludrocortisone may correct hyperkalemia and hypotension and improve hyperuricemia but does not ameliorate hemoglobin levels.\u00a0Fludrocortisone may slow chronic kidney disease progression by lowering renin production (both the normal and the mutated renin). [6]"}
{"id": "article-24904_32", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management", "content": "For ADTKD-HNF1B,\u00a0there is no specific therapy for this disease. The treatment is mainly supportive of chronic kidney disease. Allopurinol or febuxostat should be considered for patients with early-onset gout to prevent\u00a0tophus development and urate accumulation.\u00a0Screening for abnormal liver function tests, hyperglycemia, hypomagnesemia, and hyperuricemia is an essential part of the management to prevent further complications. Renal ultrasound should be performed to evaluate renal morphologic abnormalities. [31] [6]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management. For ADTKD-HNF1B,\u00a0there is no specific therapy for this disease. The treatment is mainly supportive of chronic kidney disease. Allopurinol or febuxostat should be considered for patients with early-onset gout to prevent\u00a0tophus development and urate accumulation.\u00a0Screening for abnormal liver function tests, hyperglycemia, hypomagnesemia, and hyperuricemia is an essential part of the management to prevent further complications. Renal ultrasound should be performed to evaluate renal morphologic abnormalities. [31] [6]"}
{"id": "article-24904_33", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management", "content": "Regarding ADTKD-SEC61A1,\u00a0there is no specific therapy to treat the underlying cause, but managing the associated congenital anemia and preventing opportunistic infection should be carried out for a better prognosis. It is important to know that patients with ADTKD are excellent candidates for kidney transplantation, particularly if there are no extra-renal manifestations. [6]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Treatment / Management. Regarding ADTKD-SEC61A1,\u00a0there is no specific therapy to treat the underlying cause, but managing the associated congenital anemia and preventing opportunistic infection should be carried out for a better prognosis. It is important to know that patients with ADTKD are excellent candidates for kidney transplantation, particularly if there are no extra-renal manifestations. [6]"}
{"id": "article-24904_34", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Differential Diagnosis", "content": "Autosomal dominant tubulointerstitial kidney disease is a congenital renal anomaly that ultimately leads to end-stage\u00a0renal disease. This condition is inherited in an autosomal dominant manner. It is essential to exclude other congenital renal diseases before making the diagnosis. [24] [25] The following consists of the most likely differential diagnosis of this condition: Early-onset autosomal dominant polycystic kidney disease Autosomal recessive\u00a0polycystic kidney disease Urinary tract obstruction Renal dysplasia Gout", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Differential Diagnosis. Autosomal dominant tubulointerstitial kidney disease is a congenital renal anomaly that ultimately leads to end-stage\u00a0renal disease. This condition is inherited in an autosomal dominant manner. It is essential to exclude other congenital renal diseases before making the diagnosis. [24] [25] The following consists of the most likely differential diagnosis of this condition: Early-onset autosomal dominant polycystic kidney disease Autosomal recessive\u00a0polycystic kidney disease Urinary tract obstruction Renal dysplasia Gout"}
{"id": "article-24904_35", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Prognosis", "content": "Although autosomal dominant tubulointerstitial kidney disease is considered benign,\u00a0most cases will ultimately develop end-stage\u00a0renal disease. To improve the prognosis, the treatment should focus on slowing the progression to ESRD. The mean age at which the\u00a0ESRD develops\u00a0is variable, and it depends on the form of the disease; it could be at a younger age, as in the teens or later in adulthood.\u00a0Lifelong treatment could control the symptoms associated with chronic kidney disease, but it will not treat the underlying cause. It was documented that renal transplantation may have an excellent prognosis, especially if the kidney is the only organ affected. [6] [29]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Prognosis. Although autosomal dominant tubulointerstitial kidney disease is considered benign,\u00a0most cases will ultimately develop end-stage\u00a0renal disease. To improve the prognosis, the treatment should focus on slowing the progression to ESRD. The mean age at which the\u00a0ESRD develops\u00a0is variable, and it depends on the form of the disease; it could be at a younger age, as in the teens or later in adulthood.\u00a0Lifelong treatment could control the symptoms associated with chronic kidney disease, but it will not treat the underlying cause. It was documented that renal transplantation may have an excellent prognosis, especially if the kidney is the only organ affected. [6] [29]"}
{"id": "article-24904_36", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Complications", "content": "ESRD\u00a0is the most critical complication associated with autosomal dominant tubulointerstitial kidney disease.\u00a0ESRD leads to variable health issues that should be addressed thoroughly and appropriately treated. [6] [29] The followings encompass the most likely complications associated with ESRD: Anemia Osteoporosis and fracture Platelet dysfunction with easy bruising Congestive heart failure Pericarditis Menstrual problems and infertility Hypertension Peripheral neuropathy Hyperkalemia and cardiac arrest In addition to the complications associated with ESRD, each form of this disease has certain complications that should be addressed as well to improve the patient quality of life as the following:", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Complications. ESRD\u00a0is the most critical complication associated with autosomal dominant tubulointerstitial kidney disease.\u00a0ESRD leads to variable health issues that should be addressed thoroughly and appropriately treated. [6] [29] The followings encompass the most likely complications associated with ESRD: Anemia Osteoporosis and fracture Platelet dysfunction with easy bruising Congestive heart failure Pericarditis Menstrual problems and infertility Hypertension Peripheral neuropathy Hyperkalemia and cardiac arrest In addition to the complications associated with ESRD, each form of this disease has certain complications that should be addressed as well to improve the patient quality of life as the following:"}
{"id": "article-24904_37", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Complications", "content": "ADTKD-UMOD\u00a0is associated with hyperuricemia and gout ADTKD-REN\u00a0is associated with hypo-proliferative anemia, hyperuricemia, mild hypotension, mild hyperkalemia ADTKD-HNF1B\u00a0is associated with\u00a0maturity-onset diabetes of the young, abnormal liver function test of unclear etiology, genito-urinary tract malformations, hyperuricemia with gout, and hypomagnesemia ADTKD-SEC61A1\u00a0is associated with anemia and neutropenia with abscess formation", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Complications. ADTKD-UMOD\u00a0is associated with hyperuricemia and gout ADTKD-REN\u00a0is associated with hypo-proliferative anemia, hyperuricemia, mild hypotension, mild hyperkalemia ADTKD-HNF1B\u00a0is associated with\u00a0maturity-onset diabetes of the young, abnormal liver function test of unclear etiology, genito-urinary tract malformations, hyperuricemia with gout, and hypomagnesemia ADTKD-SEC61A1\u00a0is associated with anemia and neutropenia with abscess formation"}
{"id": "article-24904_38", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Consultations", "content": "The management of autosomal dominant tubulointerstitial kidney disease and its complications require an interprofessional team consisting of the following: Nephrologist Hepatologist Cardiologist Hematologist Nurse practitioners Pharmacists Hemodialysis technicians", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Consultations. The management of autosomal dominant tubulointerstitial kidney disease and its complications require an interprofessional team consisting of the following: Nephrologist Hepatologist Cardiologist Hematologist Nurse practitioners Pharmacists Hemodialysis technicians"}
{"id": "article-24904_39", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Deterrence and Patient Education", "content": "Patients with autosomal dominant tubulointerstitial kidney disease should be informed about this disease's congenital nature. Health professionals should clarify that there are no available medications to treat the underlying cause. The management plan should focus on preventive measures to slow the progression of the disease to\u00a0ESRD and relieve the symptoms associated with each form of the disease.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Deterrence and Patient Education. Patients with autosomal dominant tubulointerstitial kidney disease should be informed about this disease's congenital nature. Health professionals should clarify that there are no available medications to treat the underlying cause. The management plan should focus on preventive measures to slow the progression of the disease to\u00a0ESRD and relieve the symptoms associated with each form of the disease."}
{"id": "article-24904_40", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Deterrence and Patient Education", "content": "Health care providers must also advise patients about the importance of medication adherence and compliance. Since this condition is transmitted in an autosomal dominant manner, other family members are likely to be affected even if they are asymptomatic, so screening for genetic mutations in the affected family members is rational. [6]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Deterrence and Patient Education. Health care providers must also advise patients about the importance of medication adherence and compliance. Since this condition is transmitted in an autosomal dominant manner, other family members are likely to be affected even if they are asymptomatic, so screening for genetic mutations in the affected family members is rational. [6]"}
{"id": "article-24904_41", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Enhancing Healthcare Team Outcomes", "content": "The management of this condition requires the collaboration of the entire\u00a0interprofessional team. The primary healthcare provider should be aware of this condition, especially if the patient presents with a progressive decline in renal function associated with bland urinary sediment. These patients should be referred to a nephrologist to manage renal insufficiency and prepare them for renal transplantation if mandatory. Nurses and pharmacists can also contribute with patient counseling about the condition, and in the case of pharmacists, regarding proper dosing and medication compliance. If it is confirmed that the patient carries the mutated gene, other family members should be screened for that mutation as their probability of being affected is high, and early screening could improve the prognosis and outcomes, so a genetics specialist may also need to be included in case management.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Enhancing Healthcare Team Outcomes. The management of this condition requires the collaboration of the entire\u00a0interprofessional team. The primary healthcare provider should be aware of this condition, especially if the patient presents with a progressive decline in renal function associated with bland urinary sediment. These patients should be referred to a nephrologist to manage renal insufficiency and prepare them for renal transplantation if mandatory. Nurses and pharmacists can also contribute with patient counseling about the condition, and in the case of pharmacists, regarding proper dosing and medication compliance. If it is confirmed that the patient carries the mutated gene, other family members should be screened for that mutation as their probability of being affected is high, and early screening could improve the prognosis and outcomes, so a genetics specialist may also need to be included in case management."}
{"id": "article-24904_42", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Enhancing Healthcare Team Outcomes", "content": "All interprofessional team members are responsible for documenting their observations and interventions in the patient's medical record, so all providers operate from the same data. If they notice any issues of concern, then open communication with appropriate team members is crucial to initiating proper therapeutic interventions so the patient will receive optimal care. This interprofessional model that includes clinicians, nurses, pharmacists, and other specialists will lead to the best patient outcomes. [Level 5]", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Enhancing Healthcare Team Outcomes. All interprofessional team members are responsible for documenting their observations and interventions in the patient's medical record, so all providers operate from the same data. If they notice any issues of concern, then open communication with appropriate team members is crucial to initiating proper therapeutic interventions so the patient will receive optimal care. This interprofessional model that includes clinicians, nurses, pharmacists, and other specialists will lead to the best patient outcomes. [Level 5]"}
{"id": "article-24904_43", "title": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Autosomal Dominant Tubulointerstitial Kidney Disease -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}